Traditional Chinese Medicine and Integrative Medicine Department, Peking University First Hospital, Beijing, China.
Spleen and Stomach Disease Department, Fangshan Hospital, Beijing University of Chinese Medicine, Beijing, China.
Front Immunol. 2024 Nov 11;15:1497461. doi: 10.3389/fimmu.2024.1497461. eCollection 2024.
Metabolic reprogramming (MR) in cancer (CA) has been a focus of intense research in the recent two decades. This phenomenon has attracted great interest because it offers potential targets for cancer therapy. To capture the intellectual landscape of this field, we conducted a bibliometric analysis to assess the scientific output, major contributors, and trends in the MR/CA research.
We performed a systematic search using the Web of Science to retrieve articles published on MR of cancer from 2006 until 2023. The bibliometric tools such as Biblioshiny, VOSviewer, and Microsoft Excel were used to identify the most prolific authors, institutions, citation patterns, and keywords. We also used co-citation analysis to map the conceptual structure of the field and identify influential publications. Furthermore, we examined the literature by analyzing publication years, citations, and research impact factors.
A total of 4,465 publications about MR/CA were retrieved. Publications on MR/CA increased rapidly from 2006 to 2023. published the most papers, while had the most citations. Highly cited papers were mainly published in , , , and . China and the United States led the way in publications and contributed the most to MR/CA research. The University of Texas System, Chinese Academy of Sciences, and Fudan University were the most productive institutions. The profitable authors were Deberardinis Ralph J and Chiarugi Paola. The current topics included MR in tumorigenesis and progression of CA, MR of tumor cells and tumor microenvironment, the effect of MR on the CA treatment, the underlying mechanisms of MR (such as gene regulation, epigenetics, extracellular vesicles, and gut microbiota), and the modulation of MR. Some topics such as tumor microenvironment, lipid MR, circular RNA, long noncoding RNA, exosome, prognostic model, and immunotherapy may be the focus of MR/CA research in the next few years.
This study evaluated the global scientific output in the field of MR/CA research, analyzing its quantitative characteristics. It identified some significant and distinguished papers and compiled information regarding the current status and evolving trends of MR/CA research.
代谢重编程(MR)在癌症(CA)中的研究是近二十年来的热点。这一现象引起了极大的关注,因为它为癌症治疗提供了潜在的靶点。为了捕捉该领域的知识图景,我们进行了文献计量分析,以评估 MR/CA 研究的科学产出、主要贡献者和趋势。
我们使用 Web of Science 进行了系统搜索,以检索 2006 年至 2023 年发表的关于癌症代谢重编程的文章。使用 Biblioshiny、VOSviewer 和 Microsoft Excel 等文献计量工具,确定了最有影响力的作者、机构、引文模式和关键词。我们还使用共引分析来绘制该领域的概念结构,并确定有影响力的出版物。此外,我们还通过分析出版物年份、引文和研究影响因子来检查文献。
共检索到 4465 篇关于 MR/CA 的出版物。从 2006 年到 2023 年,关于 MR/CA 的出版物数量迅速增加。美国发表的论文最多,而中国获得的引文最多。高被引论文主要发表在《自然》《细胞》《科学》《柳叶刀》和《国家癌症研究所杂志》上。中国和美国在论文发表和对 MR/CA 研究的贡献方面处于领先地位。最有成效的机构是德贝里尼达斯·拉尔夫 J 和基亚鲁吉·帕奥拉。主要的高产作者是德贝里尼达斯·拉尔夫 J 和基亚鲁吉·帕奥拉。目前的研究课题包括肿瘤发生和 CA 进展中的 MR、肿瘤细胞和肿瘤微环境中的 MR、MR 对 CA 治疗的影响、MR 的潜在机制(如基因调控、表观遗传学、细胞外囊泡和肠道微生物群)以及 MR 的调节。一些研究课题,如肿瘤微环境、脂质 MR、环状 RNA、长非编码 RNA、外泌体、预后模型和免疫治疗,可能是未来几年 MR/CA 研究的重点。
本研究评估了 MR/CA 研究领域的全球科学产出,分析了其定量特征。它确定了一些重要和有区别的论文,并汇编了关于 MR/CA 研究现状和发展趋势的信息。